Title
Category
Credits
Event date
Cost
  • Testicular Cancer
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
$0.00
These NCCN Guidelines Insights discuss the current treatment recommendations and supporting clinical data for seminomas as presented in Version 2.2025 of the NCCN Guidelines for Testicular Cancer.
  • Chronic Lymphocytic Leukemia
  • 2.00 AAPA Category 1 CME credit
  • 2.00 ACPE contact hours
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 ANCC contact hours
  • 2.00 Participation
$0.00
The goal of this activity is to improve learners’ knowledge, competence, and confidence to integrate new and emerging therapies into practice to improve clinical outcomes in patients with chronic lymphocytic leukemia / small lymphocytic lymphoma.
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ABIM Medical Knowledge
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
$0.00
Expert faculty provide a comprehensive overview of bispecific antibodies in relapsed/refractory multiple myeloma, including clinical considerations, common toxicities, and prophylaxis and management strategies.
  • Pain
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 ASWB continuing education credit
  • 1.00 Participation
$0.00
This session will delve into the fundamental concepts of cancer pain management, focusing on the underlying mechanisms of pain in oncology and the assessment of pain in cancer patients. The session will cover cancer-specific pain definitions, the physiology of pain in different types of cancer, and effective pain assessment strategies tailored to oncology practice.Provided by the National Comprehensive Cancer Network in collaboration with The France Foundation.
  • Pain
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 ASWB continuing education credit
  • 1.00 Participation
$0.00
This session will explore the range of therapeutic options available for managing cancer pain, encompassing both pharmacological and non-pharmacological approaches. Participants will learn about the appropriate use of non-opioid and opioid analgesics in cancer pain management, as well as complementary therapies and interventional techniques.Provided by the National Comprehensive Cancer Network in collaboration with The France Foundation.
  • Pain
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 ASWB continuing education credit
  • 1.00 Participation
$0.00
This session will focus on the safe and effective integration of opioid analgesics into cancer pain treatment plans. Participants will learn how to initiate, titrate, and discontinue opioid therapy for acute and chronic cancer pain, while considering factors such as pain severity, treatment goals, and patient preferences. Strategies for minimizing opioid-related risks and maximizing functional improvement will also be discussed. Provided by the National Comprehensive Cancer Network in collaboration with The France Foundation.
  • Pain
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 ASWB continuing education credit
  • 1.00 Participation
$0.00
This session will explore the importance of interdisciplinary collaboration in optimizing cancer pain management. Topics will include recognizing indications for referral to pain specialists, effective communication and teamwork among healthcare providers, and strategies for managing opioid use disorders in cancer patients. The session will emphasize a patient-centered approach to care and the role of the oncologist as part of a multidisciplinary team.Provided by the National Comprehensive Cancer Network in collaboration with The France Foundation.
  • Prostate Cancer
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
$0.00
It is important to stay up to date with the latest therapy options available, review the latest mCRPC systemic therapy recommendations, and understand the data behind them.
$0.00
The goal of this initiative is to provide education to clinicians, involved in the assessment and management of cancer pain in adult patients, on the appropriate and safe use of opioid analgesics, optimizing non-opioid analgesics and adjuvant medications, and integrating non-pharmacological approaches into cancer pain management. Provided by the National Comprehensive Cancer Network in collaboration with The France Foundation.
  • Non-Hodgkin's Lymphoma
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 CCM clock hours
  • 1.00 Participation
$0.00
T-cell engager therapy with bispecific antibodies is emerging as a promising treatment option for patients with heavily pretreated DLBCL. Careful monitoring of adverse events and implementing appropriate supportive care strategies is important to maximize the clinical benefit.

Pages